Creative Medical Technology Holdings Inc (CELZ)
4.41
-0.03
(-0.68%)
USD |
NASDAQ |
May 15, 14:33
Creative Medical Technology Holdings Cash from Investing (Quarterly): 1.126M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.126M |
September 30, 2023 | 1.822M |
June 30, 2023 | -4.540M |
March 31, 2023 | 5.037M |
December 31, 2022 | -5.057M |
September 30, 2022 | -5.021M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.20M |
September 30, 2021 | -0.20M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | -0.25M |
September 30, 2020 | 0.00 |
June 30, 2020 | |
March 31, 2020 | 0.00 |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | 0.10M |
June 30, 2017 | -0.10M |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | -0.01M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.057M
Minimum
Dec 2022
5.037M
Maximum
Mar 2023
-0.4589M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
Avid Bioservices Inc | -4.488M |
Viking Therapeutics Inc | -459.79M |
Avinger Inc | 0.00 |
Aptevo Therapeutics Inc | 0.00 |
Absci Corp | 18.96M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.895M |
Cash from Financing (Quarterly) | -0.271M |
Free Cash Flow | -8.128M |
Free Cash Flow Per Share (Quarterly) | -1.372 |
Free Cash Flow to Equity (Quarterly) | -1.895M |
Free Cash Flow to Firm (Quarterly) | -1.895M |
Free Cash Flow Yield | -130.9% |